During the past decade, Magyar Honvédség Egészségügyi Központ Onkológiai Osztály conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 5 clinical trials were completed, i.e. on average, 45.5% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 5 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Magyar Honvédség Egészségügyi Központ Onkológiai Osztály" #1 sponsor was "Hoffmann-La Roche" with 4 trials, followed by "Institut de Recherches Internationales Servier" with 2 trials sponsored, "Pfizer" with 2 trials sponsored, "Blueprint Medicines Corporation" with 1 trials sponsored and "Millennium Pharmaceuticals, Inc." with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Magyar Honvédség Egészségügyi Központ Onkológiai Osztály" #1 collaborator was "ADIR, a Servier Group company" with 2 trials as a collaborator, "Institut de Recherches Internationales Servier" with 1 trials as a collaborator and "Medivation, Inc." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Magyar Honvédség Egészségügyi Központ Onkológiai Osztály" are "Breast Cancer" (2 trials), "Metastatic Colorectal Cancer" (2 trials), "Advanced Solid Tumors, Neoplasms, Advanced Solid" (1 trials), "Cancer" (1 trials) and "Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer" (1 trials). Many other conditions were trialed in "Magyar Honvédség Egészségügyi Központ Onkológiai Osztály" in a lesser frequency.

Most popular intervention types in "Magyar Honvédség Egészségügyi Központ Onkológiai Osztály" are "Drug" (12 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Docetaxel" (3 trials), "Atezolizumab" (2 trials), "Bevacizumab" (2 trials), "Giredestrant" (2 trials) and "LHRH Agonist" (2 trials). Other intervention names were less common.

The vast majority of trials in "Magyar Honvédség Egészségügyi Központ Onkológiai Osztály" are 11 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Magyar Honvédség Egészségügyi Központ Onkológiai Osztály". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Magyar Honvédség Egészségügyi Központ Onkológiai Osztály, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Magyar Honvédség Egészségügyi Központ Onkológiai Osztály, 2 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".